Physician profile
Noah Harrison Prince
NPI 1750721585
$3,588.60
in general payments reported to CMS, 2019-2025
17 companies · $337 in 2025
The $337 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $727 · 2020: $22.64 · 2021: $110 · 2022: $672 · 2023: $1,352 · 2024: $368 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,157 · Consulting Fee: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,157.16 |
| Consulting Fee | $900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $1,350.00 | 2022-2023 | |
| Innovation Technologies INC | $398.32 | 2022-2025 | Irrisept |
| Abbvie INC. | $374.77 | 2023-2025 | |
| Mentor Worldwide LLC | $293.54 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Sientra, INC. | $289.87 | 2019-2021 | |
| Medical Device Business Services, INC. | $259.99 | 2019 | |
| Stryker Corporation | $193.28 | 2022-2023 | Spy-Phi System |
| Axogen | $115.79 | 2019-2021 | |
| Galderma Laboratories, L.P. | $95.75 | 2019 | |
| Ethicon US, LLC | $59.65 | 2019-2025 | Dermabond, Monocryl, Dermabond Prineo |
| Allergan, INC. | $31.14 | 2021-2022 | |
| Smith+Nephew, INC. | $28.69 | 2024-2025 | Stravix Pl, Oasis |
| Janssen Biotech, INC. | $27.16 | 2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $23.55 | 2025 | Libtayo |
| Incyte Corporation | $22.06 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $13.83 | 2019 | |
| Kerecis Limited | $11.21 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noah Prince listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.